First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB

Joseph M Lewis, Paul Hine, Jenny Walker, Saye H Khoo, Miriam Taegtmeyer, S Bertel Squire, Derek J Sloan

Research output: Contribution to journalLetterpeer-review

24 Citations (Scopus)

Abstract

The first successful use of bedaquiline for 18 months for XDR-TB as part of an optimised background regimen
Original languageEnglish
JournalEuropean Respiratory Journal
DOIs
Publication statusPublished - 25 Feb 2016

Fingerprint

Dive into the research topics of 'First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB'. Together they form a unique fingerprint.

Cite this